Microbot Medical Stock Is Moving Higher: What's Going On?
Microbot Medical Inc MBOT | 0.00 |
Microbot Medical Inc (NASDAQ:MBOT) shares are trading higher Thursday after the company announced the completion of its GLP pivotal pre-clinical study.
What To Know: Three interventional radiologists utilized Microbot's LIBERTY Endovascular Robotic Surgical System to perform a total of 96 robotic navigations under FDA guidelines. Microbot said all study objectives were met.
The medical device company noted that the results gave it confidence to move on to human studies. Microbot plans to submit an IDE application to the FDA soon as it transitions to a clinical-stage company.
"I am very pleased with the positive outcomes of the histopathology report and the completion of the GLP study. This gives us confidence to move forward to the next stage of human clinical studies," said Juan Diaz Cartelle, chief medical officer of Microbot.
Microbot is trending across various social platforms on Thursday. The stock may be getting a boost from retail trading activity.
Check This Out: 60/40 Portfolio Bounces Back From 2022 Slump: Is It The Right Investment Strategy For 2024?
MBOT Price Action: Microbot shares were up 40% at $1.85 at the time of publication, according to Benzinga Pro.
Photo: StockSnap from Pixabay.
Recommend
- Sahm Platform 12/10 06:15
How Does Atlantic Union Bankshares Stack Up After Announcing Its Latest Dividend Increase?
Simply Wall St 12/10 20:19Option Signals | Broadcom Options Active on OpenAI Deal; Beyond Meat Call Volume Surges Despite 48% Stock Plunge
Sahm Platform 14/10 08:25BRIEF-Microbot Medical Inc Files For Offering Of Up To 14.7 Million Shares Of Common Stock By The Selling Stockholders - SEC Filing
Reuters 14/10 11:06Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
Reuters 14/10 12:30Microbot Medical Partners With U.S. Based 3PL Company To Support Commercialization Of FDA-Cleared LIBERTY System
Benzinga News 14/10 12:32Financial Morning Summary | PIF Assets Jump 42% to SAR 206.2B; RETAL(4322) Wins SAR 461.9M ROSHN Contract; IMF Projects 4% Saudi Growth
Sahm Platform Today 05:51HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target
Benzinga News 1h